臺大學術期刊資料庫NTU Journal Database

嚴重型心臟血管疾病之改善效益衡量-特徵價格法之應用

Evaluating the Benefits of Ameliorating Serious Cardiovascular Disease-An Application of the Hedonic Pricing Method

李杰憲(Chieh-Hsien Lee);傅祖壇(Tsu-Tan Fu)

佛光大學經濟學系(Department of Economics, Fo Guang University);國立臺灣大學農業經濟學系(Department of Agricultural Economics, National Taiwan University)

卷期
36卷1期
出版
2008年03月
頁碼
001–037
編號
NTUEJ00006854
外部連結本篇全文由原出版單位的網站提供。

連結出處:C.E.P.S思博網。連結會開啟本資料庫以外的網站,能否閱讀由該網站決定。

摘要

本文以特徵價格法,衡量嚴重型心臟血管疾病之改善效益。我們發現若能改善嚴重型心臟血管疾病患者的高血壓、高膽固醇、糖尿病等風險因子至正常的水準,在二次醫療照護支出函數模型及半對數醫療照護支出函數模型的實證結果顯示,患者一整年對於嚴重型心臟血管疾病的醫療照護支出約可減少10.7億元、4.23億元、4.18億元及15.7億元、5.08億元、11.3億元。結果顯示改善高血壓所獲得之經濟效益較大。在醫療資源有限的情況下,考慮較易達成的改善高血壓,卻能讓患者減少較多的醫療照護支出,相信對於嚴重型心臟血管疾病的防治有事半功倍之效,值得有關單位重視。

Abstract

This paper uses the hedonic price method (HPM) to evaluate the benefits from ameliorating serious cardiovascular disease. Data from the CVDFACTS project and NHI are used for the empirical analysis. Results using the quadratics model show that if we can ameliorate risk factors, such as hypertension, cholesterol and diabetes, among serious cardiovascular disease sufferers so that the risk levels are no higher than found in the general population the cost of medical service can be reduced NT$1,070, 423 and 418 million respectively. Using the log-linear model, results are NT$1,570, 508 and 1,130 respectively. Compared to cholesterol and diabetes, hypertension is relatively easy to ameliorate and the benefit is higher. In order to effectively prevent serious cardiovascular disease, the government needs to shift medical resources towards improving hypertension.

關鍵詞

程式與 AI 助手可以改用資料介面(JSON、MCP),查詢比讀頁面快。給程式與 AI 代理的存取說明